Skip Intro

Proteon Therapeutics

In May of 2014, Deerfield invested in Proteon Therapeutics, Inc. as part of $45 million Series D financing. Proteon is a development stage biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases.